https://www.pharmaglobenewswire.com/minimal-residual-disease-market-set-to-witness-significant-growth-driven-by-rising-cancer-incidence-technological-advancements-and-expanding-testing-adoption-through-2032/Pharma Globenewswireen2026-07-17T10:48:04+01:00Minimal Residual Disease Market Set to Witness Significant Growth Driven by Rising Cancer Incidence, Technological Advancements, and Expanding Testing Adoption Through 2032 https://www.pharmaglobenewswire.com/the-global-herbal-medicine-market-was-valued-at-usd-71445-63-million-in-2024-growing-at-a-cagr-of-10-18-to-reach-usd-154072-10-million-by-2032-estimates-delveinsight/Pharma Globenewswireen2026-07-16T12:42:32+01:00The Global Herbal Medicine Market was valued at USD 71,445.63 million in 2024, growing at a CAGR of 10.18% to reach USD 154,072.10 million by 2032, estimates DelveInsight https://www.pharmaglobenewswire.com/liquid-biopsy-in-cancer-diagnostics-market-set-to-witness-significant-growth-driven-by-rising-cancer-burden-genomic-innovation-and-expanding-clinical-adoption-through-2034/Pharma Globenewswireen2026-07-16T11:57:42+01:00Liquid Biopsy in Cancer Diagnostics Market Set to Witness Significant Growth Driven by Rising Cancer Burden, Genomic Innovation, and Expanding Clinical Adoption Through 2034